SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $884,000 | -24.8% | 26,701 | -3.4% | 0.00% | -25.0% |
| Q4 2021 | $1,176,000 | -7.5% | 27,647 | -3.6% | 0.00% | -20.0% |
| Q3 2021 | $1,271,000 | -23.7% | 28,688 | -2.2% | 0.01% | -16.7% |
| Q2 2021 | $1,666,000 | -18.1% | 29,327 | +7.9% | 0.01% | -25.0% |
| Q1 2021 | $2,034,000 | -6.5% | 27,177 | +8.1% | 0.01% | -20.0% |
| Q4 2020 | $2,175,000 | +75.4% | 25,143 | +23.9% | 0.01% | +42.9% |
| Q3 2020 | $1,240,000 | +52.9% | 20,287 | +4.0% | 0.01% | +40.0% |
| Q2 2020 | $811,000 | +37.2% | 19,515 | -5.2% | 0.01% | +25.0% |
| Q1 2020 | $591,000 | -52.8% | 20,586 | +18.6% | 0.00% | -33.3% |
| Q4 2019 | $1,253,000 | -69.6% | 17,356 | -40.9% | 0.01% | -72.7% |
| Q3 2019 | $4,118,000 | -40.8% | 29,351 | -22.7% | 0.02% | -40.5% |
| Q2 2019 | $6,952,000 | +6.8% | 37,971 | -7.2% | 0.04% | +8.8% |
| Q1 2019 | $6,508,000 | +147.5% | 40,921 | +49.0% | 0.03% | +126.7% |
| Q4 2018 | $2,630,000 | -44.9% | 27,460 | -18.7% | 0.02% | -34.8% |
| Q3 2018 | $4,770,000 | -14.0% | 33,773 | -4.7% | 0.02% | -17.9% |
| Q2 2018 | $5,546,000 | +150.5% | 35,430 | +157.8% | 0.03% | +133.3% |
| Q1 2018 | $2,214,000 | – | 13,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |